Limited time75% off all plans
Get the app

Treatment guidelines for invasive fungal infections

Treatment guidelines for invasive fungal infections

Treatment guidelines for invasive fungal infections

On this page

Empiric Therapy - First Strike Fungi

  • Indicated for high-risk, febrile neutropenic patients with persistent or recurrent fever after 4-7 days of broad-spectrum antibiotics, with no other identified cause.
  • Goal: Preemptively cover the most probable fungal pathogens, primarily Candida species and Aspergillus.
  • De-escalate to targeted therapy once a pathogen is identified and susceptibilities are determined.

⭐ Echinocandins are favored as initial therapy for most patients with suspected invasive candidiasis, particularly those who are hemodynamically unstable or had recent azole exposure.

Invasive Candidiasis - Crushing Candida

  • Empiric First-Line: Echinocandins (e.g., caspofungin, micafungin) for most patients, especially if moderately to severely ill or recent azole exposure.
  • Step-Down Therapy: Transition to Fluconazole within 5-7 days if patient is stable, isolates are susceptible, and blood cultures are negative.
  • Specific Species:
    • C. krusei: Intrinsically resistant to fluconazole; use echinocandins.
    • C. glabrata: May have dose-dependent susceptibility to fluconazole; echinocandins are safer.
  • Duration: Treat for 14 days after the first negative blood culture and clinical resolution.

⭐ Source control is paramount. If a central line is the suspected source, it must be removed as soon as possible.

Invasive Aspergillosis - Voriconazole's Victory

  • Primary Therapy: Voriconazole is the drug of choice, demonstrating superior efficacy over Amphotericin B.

    • Requires therapeutic drug monitoring (TDM) due to variable metabolism.
    • Key ADRs: Visual disturbances (flashing lights), photosensitivity, ↑LFTs.
  • Alternative Agents:

    • Liposomal Amphotericin B (L-AMB).
    • Isavuconazole (less hepatotoxicity and no photosensitivity).

Exam Favorite: Voriconazole is active against Candida (including krusei) and Aspergillus, but critically lacks coverage for Zygomycetes (Mucor, Rhizopus).

Other Key Pathogens - Crypto & Mucor Mayhem

  • Cryptococcus neoformans (Meningitis)

    • 📌 Amp-ho-Flu → Flu: Amphotericin B + Flucytosine, then Fluconazole.
    • Induction: Liposomal Amphotericin B + Flucytosine (≥2 weeks).
    • Consolidation & Maintenance: Fluconazole (high-dose for 8 weeks, then low-dose ≥1 year).
  • Mucormycosis (e.g., Rhizopus, Mucor)

    • Cornerstone: Aggressive surgical debridement.
    • Medical: High-dose Liposomal Amphotericin B.
    • Alternatives: Posaconazole, Isavuconazole.

Mucormycosis: Broad non-septate hyphae at 90-degree angles

⭐ Voriconazole is ineffective against Mucorales. Prior voriconazole prophylaxis is a risk factor for breakthrough mucormycosis.

  • Invasive Aspergillosis: Voriconazole is the drug of choice; alternatives include isavuconazole or liposomal amphotericin B.
  • Invasive Candidiasis: First-line therapy is an echinocandin (e.g., caspofungin, micafungin); fluconazole for step-down.
  • Cryptococcal Meningitis: Induction with amphotericin B + flucytosine, followed by fluconazole for consolidation and maintenance.
  • Mucormycosis: Requires aggressive surgical debridement plus liposomal amphotericin B.
  • Febrile Neutropenia: Add empiric antifungals if fever persists on broad-spectrum antibiotics.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS
Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Everything you need for USMLE prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE